Paeds · infectious-diseases
Staphylococcal scalded skin syndrome
Also known as Staphylococcal scalded skin syndrome · SSSS · Ritter disease · Pemphigus neonatorum · Lyell disease (staphylococcal) · Generalised bullous impetigo
Fellowship guide to staphylococcal scalded skin syndrome: the toxin-mediated blistering disorder of infants and young children produced when phage-group-II Staphylococcus aureus releases exfoliative toxins A and B that cleave desmoglein 1. Covers the bullous impetigo, scarlatiniform, and generalised (Ritter) phenotypes, the mucosa-sparing superficial split that separates it from Stevens-Johnson syndrome and toxic epidermal necrolysis, the mostly negative blood cultures, anti-staphylococcal antibiotics with clindamycin for toxin suppression, and the child's near-complete recovery without scarring.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- A febrile infant with rapidly spreading tender erythema that evolves into flaccid bullae and sheet-like peeling within hours
- Positive Nikolsky sign with skin shearing off on light stroking in an unwell young child
- Perioral fissuring and radial crusting giving a sad-man facies with widespread desquamation
- Temperature instability, poor feeding, or dehydration from fluid loss across the raw skin surface
- An adult or older child with the same picture, because this host cannot clear the toxin and carries high mortality
- Mucosal involvement accompanying the blistering, which points away from SSSS toward SJS or TEN
- Recurrence in a very low birth weight neonate, which signals a persistent carrier focus or immune failure
Life stages
Care settings
Clinical exam formats
Board mappings
- Recognises staphylococcal scalded skin syndrome from tender erythema, flaccid bullae, and perioral fissuring in an infant
- Identifies the sparing of mucous membranes as the key clue against Stevens-Johnson syndrome
- Initiates anti-staphylococcal antibiotics and supportive skin care
- Explains the desmoglein 1 cleavage mechanism and why the split is superficial and mucosa-sparing
- Selects flucloxacillin or cefazolin with clindamycin for toxin suppression, adding vancomycin for MRSA
- Investigates a nosocomial nursery outbreak and manages carrier staff
- Assessment and initial management of a febrile infant with widespread desquamation
- Differentiating SSSS from SJS, TEN, and toxic shock syndrome
- Counselling parents about the usually complete recovery without scarring
- Bedside recognition of the Nikolsky sign and the sad-man facies
- Communication of the diagnosis, the antibiotic plan, and the expected course
- Structuring the search for the staphylococcal focus
- Level 1: Recognises the acutely unwell infant with blistering and desquamation
- Level 2: Investigates and begins empiric anti-staphylococcal treatment
- Level 3: Manages complications, fluid loss, and neonatal outbreak control
- Pathogenesis: exfoliative toxins A and B cleave desmoglein 1
- Clinical and laboratory distinction from SJS, TEN, and Kawasaki disease
- Antibiotic regimens and the role of clindamycin for toxin suppression
- Examination of an infant with blistering and identification of mucosal sparing
- Communication with parents about prognosis and skin care
- Structured assessment of a neonate with a suspected nursery outbreak
- Diagnosis of SSSS from clinical features and the Nikolsky sign
- Empiric anti-staphylococcal therapy and supportive management
- Recognition of severe disease with fluid and temperature dysregulation
- Rapid recognition of the toxin-mediated blistering infant
- Appropriate antibiotic and fluid management
- Infection control and prevention of nosocomial spread
- Canadian approach to paediatric SSSS and the role of clindamycin
- Distinguishing SSSS from drug-induced TEN and Kawasaki
- Nursery outbreak investigation and carrier eradication
Overview & Definition
A fretful, febrile infant whose skin turns scarlet and then peels off in sheets is one of the most arresting sights in paediatrics, and staphylococcal scalded skin syndrome is the diagnosis that explains it. Phage-group-II Staphylococcus aureus, often colonising a trivial focus such as a sticky eye or an umbilical stump, releases exfoliative toxins A and B that travel in the blood and split the superficial epidermis. The result is tender erythema, fragile blisters, and widespread desquamation that looks like a scald but heals without scarring in a child who is treated promptly. [2]
The illness belongs to the family of staphylococcal exfoliative toxin diseases, which span from localised bullous impetigo at one end to generalised SSSS, also known as Ritter disease, at the other. The dividing line is whether the toxin stays local or reaches the circulation, and that in turn depends on the bacterial strain and on the host's ability to clear the toxin through the kidneys. Infants and children under six years cannot excrete the toxin as efficiently as adults, which is why this is overwhelmingly a disease of the very young. [1]
The single most important clinical point is that the mucous membranes are spared. The toxin cleaves desmoglein 1, which is expressed in the superficial epidermis of skin but is compensated for in mucosa by desmoglein 3, so the mouth, eyes, and genital surfaces remain intact. This single fact separates SSSS from Stevens-Johnson syndrome and toxic epidermal necrolysis, in which mucosal involvement is the rule and the split is full-thickness. Getting that distinction right at the bedside dictates the antibiotic choice, the prognosis, and the conversation with a frightened family. [3]
References12ShowHide
- [1]Ladhani S Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev, 1999.PMID 10194458
- [2]Ladhani S Staphylococcal scalded skin syndrome. Arch Dis Child, 1998.PMID 9534685
- [3]Handler MZ Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol, 2014.PMID 24841497
- [4]Patel GK Treatment of staphylococcal scalded skin syndrome. Expert Rev Anti Infect Ther, 2004.PMID 15482221
- [5]Patel GK Staphylococcal scalded skin syndrome: diagnosis and management. Am J Clin Dermatol, 2003.PMID 12627992
- [6]Hanakawa Y Mechanisms of blister formation by staphylococcal toxins. J Biochem, 2004.PMID 15671483
- [7]Mockenhaupt M Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol, 2005.PMID 15816826
- [8]El Helali N Nosocomial outbreak of staphylococcal scalded skin syndrome in neonates: epidemiological investigation and control. J Hosp Infect, 2005.PMID 16009455
- [9]Soti Khiabani M Ten-Year Epidemiology and Antimicrobial Susceptibility of Pediatric Staphylococcal Scalded Skin Syndrome: A Retrospective Study From a Tertiary Referral Center. Pediatr Dermatol, 2026.PMID 42219159
- [10]Ladhani S Isolating Staphylococcus aureus from children with suspected Staphylococcal scalded skin syndrome is not clinically useful. Pediatr Infect Dis J, 2003.PMID 12664881
- [11]Duijsters CE Recurring staphylococcal scalded skin syndrome in a very low birth weight infant: a case report. J Med Case Rep, 2009.PMID 19830179
- [12]Ladhani S Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. FEMS Immunol Med Microbiol, 2003.PMID 14625102